Intracellular Nanomaterial Delivery via Spiral Hydroporation by GeoumYoung Kang et al.
Intracellular Nanomaterial Delivery via Spiral
Hydroporation
Author GeoumYoung Kang, Daniel W. Carlson, Tae Ho
Kang, Seungki Lee, Simon J. Haward, Inhee
Choi, Amy Q. Shen, Aram J. Chung
journal or
publication title
ACS Nano
volume 14
number 3
page range 3048-3058
year 2020-02-18
Publisher American Chemical Society
Rights (C) 2020 American Chemical Society
ACS AuthorChoice with CC-BY-NC-ND
Author's flagpublisher
URL http://id.nii.ac.jp/1394/00001312/
doi: info:doi/10.1021/acsnano.9b07930
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International 
(https://creativecommons.org/licenses/by-nc-nd/4.0/)
Intracellular Nanomaterial Delivery via Spiral
Hydroporation
GeoumYoung Kang, Daniel W. Carlson, Tae Ho Kang, Seungki Lee, Simon J. Haward, Inhee Choi,
Amy Q. Shen, and Aram J. Chung*
Cite This: ACS Nano 2020, 14, 3048−3058 Read Online
ACCESS Metrics & More Article Recommendations *sı Supporting Information
ABSTRACT: In recent nanobiotechnology developments, a
wide variety of functional nanomaterials and engineered
biomolecules have been created, and these have numerous
applications in cell biology. For these nanomaterials to fulfill
their promises completely, they must be able to reach their
biological targets at the subcellular level and with a high level of
specificity. Traditionally, either nanocarrier- or membrane
disruption-based method has been used to deliver nanomateri-
als inside cells; however, these methods are suboptimal due to
their toxicity, inconsistent delivery, and low throughput, and
they are also labor intensive and time-consuming, highlighting
the need for development of a next-generation, intracellular
delivery system. This study reports on the development of an intracellular nanomaterial delivery platform, based on
unexpected cell-deformation phenomena via spiral vortex and vortex breakdown exerted in the cross- and T-junctions at
moderate Reynolds numbers. These vortex-induced cell deformation and sequential restoration processes open cell
membranes transiently, allowing effective and robust intracellular delivery of nanomaterials in a single step without the aid of
carriers or external apparatus. By using the platform described here (termed spiral hydroporator), we demonstrate the delivery
of different nanomaterials, including gold nanoparticles (200 nm diameter), functional mesoporous silica nanoparticles (150
nm diameter), dextran (hydrodynamic diameters between 2−55 nm), and mRNA, into different cell types. We demonstrate
here that the system is highly efficient (up to 96.5%) with high throughput (up to 1 × 106 cells/min) and rapid delivery (∼1
min) while maintaining high levels of cell viability (up to 94%).
KEYWORDS: intracellular delivery, nanoparticle delivery, macromolecule delivery, cell transfection, hydroporator, hydroporation,
inertial microfluidics
Nanomaterials such as functional nanoparticles andsynthetic biomolecules have attracted considerableattention, particularly from the cell biology commun-
ity.1−6 For instance, gold nanoparticles (GNPs) can be
synthesized with specific shapes and configurations and can
be conjugated with other materials for drug delivery, imaging,
single-molecule, or subcellular organelle tracking, biosensing,
and diagnosis.1−3 As another example, genetic nanomaterials
such as DNAs, RNAs, or RNA/DNA nanovehicles4 can be
synthesized and introduced into cells for cell-based therapy,
gene editing, and cell reprogramming.5,6 To achieve the
desired functions, nanomaterials must pass through the lipid
bilayer cell membrane that separates the cell interior from the
environment. Because cell membranes selectively and actively
control the entry of substances into cells, using membrane
transport protein channels (known as endocytosis),7 only small
molecules, particles, and ions can easily diffuse or pass through
them. Thus, for larger nanomaterials, effective uptake via
endocytosis is difficult to achieve without complex nanoma-
terial chemical surface modification.
To facilitate the nanomaterial endocytic process, numerous
synthetic nanocarriers such as lipids, polymers, inorganic
nanomaterials, cell-penetrating peptides (CPPs), and other
targeting or stabilizing agents have been developed.8 These
nanocarriers can cross the cell membrane because they take
advantage of natural endocytic pathways based on their cell
membrane interactions and physicochemical properties.
However, nanomaterials often reside in liposomal vesicles
without being exposed to the intracellular environment (i.e.,
endosomal entrapment), which leads to the degradation of
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lysosomes or regurgitation back to the cell surface.9 For nucleic
acid delivery, viral carriers (e.g., vectors such as lentivirus,
retrovirus, and adenovirus) are highly preferred to transfect
cells owing to their high specificity. However, the safety, cost,
and complexity of their preparation are critical concerns,10
indicating that true, accurate, safe, and cost-effective internal-
ization of nanomaterials remains a long-standing challenge.
Alternatively, an entry point on the cell membrane can be
created by applying external physical forces. For instance, the
cell membrane can be opened by microinjection, using a sharp
glass micropipette to insert nanomaterials into the cells.
Electroporation is another entry mechanism example, and in
this method, discontinuities are created in cell and nuclear
membranes by applying a high voltage. These membrane
disruption-based techniques permit target nanomaterial- and
cell-type-insensitive delivery; however, excessive cell damage,
inconsistent delivery, and low scalability are unavoidable
drawbacks.
To address this open challenge, micro- and nanotechnolo-
gies have been investigated, leading to a wide variety of
solutions.11−19 Among these, microfluidics have exhibited high
potential because of their precise fluidic controls and cell
manipulation with high spatiotemporal resolution.20 Most
state-of-the-art, microfluidic delivery platforms mechanically
deform cells without external forces, using mechanisms
involving electrical or acoustic forces, for example, to create
transient discontinuities in the cell membrane either by passing
cells through narrow channel structures such as bottlenecks/
ridges21−24 or poking cells.25,26 These microfluidic approaches
have high promises for the delivery of various nanomaterials;
however, their designs are susceptible to clogging, which is a
nontrivial issue, substantially lowering their practicality.
Recently, Kizer et al.,27 reported a microfluidic, clogging-
free, nanomaterial intracellular delivery platform that hydro-
dynamically deforms cells in a cross-junction, producing
transient nanopores in the cell membrane. The platform
successfully delivered a varied selection of molecules; however,
the delivery of larger nanomaterials (>50 nm) was limited
owing to a lack of knowledge about the fluid−cell interactions.
It must be mentioned that there is a predominant
misconception in the microfluidics field that “symmetric and
uniform planar extensional flow” arises in a cross-junction
channel at moderate Reynolds numbers (Re; a dimensionless
parameter describing the ratio of inertial force to viscous
force), resulting in symmetric cell elongation.28 In fact, this is
only true at low Re flows.29
In this study, we introduce an unexpected cell deformation
phenomenon that leverages the spiral vortex and vortex
breakdown in a cross-junction at moderate Re, leading to
highly effective intracellular delivery of large nanomaterials.
Briefly, in this method, cells in the spiral vortex flow undergo
an intrinsic hydrodynamic cell deformation−restoration
process (we subsequently refer to this mechanism as “spiral
hydroporation”), which opens the cell membrane, allowing
rapid transport of exogenous nanomaterials into the cytosol.
Based on this spiral hydroporation platform, we have achieved
the highly efficient (up to 96.5%), high-throughput (up to 1 ×
106 cells/min), rapid (∼1 min) delivery of different large
nanoparticles (200 nm gold and 150 nm mesoporous silica
nanoparticles) and macromolecules (>2000 kDa dextran and
996 nt mRNA) into cells while maintaining high cell viability
(up to 94%).
RESULTS AND DISCUSSION
Design and Operating Principles. The presented spiral
hydroporation platform (Figure 1C) comprises a cross-
junction and two dividing T-junction channels. The cell
suspension, with target nanomaterials mixed in, is pumped into
two opposing channels at different flow rates (Re ≈ 0−366)
and exits through two opposing outlet T-junction channels.
We found that at moderate Re, instead of symmetric cell
elongation,28 the cells spiral down, exhibiting large deforma-
tion as they approach the stagnation point (see Figure 1B and
Movies S1 and S2). With respect to the cross-junction
geometry, it has been reported that such intersecting flows
are prone to instability,30 and we postulated that flow
instability near the stagnation point induces a strong spiral
vortex, accounting for the observed cell deformation
phenomenon. The observed spiral flow motion/pattern agrees
very well with that reported by Haward et al.31,32 who
Figure 1. Spiral hydroporation for intracellular nanomaterial delivery. (A) Schematic depicting spiral flow motion at a cross-junction
channel. (B) (1) Illustration of spiral vortex-induced cell deformation and (2) high-speed microscope images showing rotational cell
motions (scale bar: 10 μm). (C) CAD layout of the hydroporation microfluidic device, consisting of (1) a cross-junction and (2) two
dividing T-junction channels. (D) Hydrodynamic cell deformation via (1) the spiral vortex at the cross-junction and (2) cell-wall collision at
the T-junction(s) (scale bars: 20 and 30 μm for (1) and (2), respectively). (E) Schematic illustrating nanomaterial delivery into cell cytosols.
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examined the spiral vortex flow (without particles or cells) in
mm-sized, cross-junction devices; for more details, refer to the
section below, in which we experimentally measure and
numerically predict vorticity at the micrometer scale.
As the cells leave the stagnation point region, they are
guided to the channel center by inertia33−35 and collide with
one of the T-junction channel walls,36 resulting in additional
cell deformation (see Figure 1D (2) and Movie S3). We
hypothesize that this repeated cell deformation−restoration
process generates more nanoholes in the cell membranes,
enabling enhanced convective and diffusive transport of the
target materials into the cytosol (see Figure 4 for details). Note
that the nanoholes created in the cell membrane (Figure 1E)
are resealed via a self-repairing mechanism within 1 min,10 and
even this time can be adjusted by modulating the solution’s
calcium concentration.37
Spiral Flow Characterization. For detailed investigation
of the spiral cell deformation phenomenon, we microscopically
investigated spiral vortex formation in a cross-junction channel
both experimentally and numerically. For flow visualization
(see Materials and Methods section for details), all experi-
ments were performed at room temperature, over a range of Re
(Re = ρUDh/μ, where ρ is the fluid density, U is the average
flow velocity, Dh is the hydraulic diameter, and μ is the
dynamic viscosity of the carrier fluid). Deionized water (DI)
was injected at both the left and right inlets, with fluorescent
dye added to the water injected on the left (see Materials and
Methods). Fluorescent images of the XY plane (top view),
which capture evolution of the vortex as a function of Re, can
be seen in Figure 2A (1). At the lowest Reynolds number, the
interface between the two fluid streams remains sharp and
symmetric, while three-dimensional, swirling motions start to
become apparent at a Reynolds number of 37.9 (defined as the
critical Reynolds number, Rec); the crossover becomes stronger
and more complex as Re increases. Note that this swirling flow
motion is completely different from what was widely believed
to be a symmetric planar extensional flow in cross-junction
channels, based on previous reports.27,28,38,39
Figure 2. Experimental and numerical flow characterization. (A) (1) Fluorescence and (2−3) confocal microscope images of the steady flow
regimes at the cross-junction, at different Re. Onset of steady engulfment flow at Rec = 37.9, and higher complex flow patterns beyond Rec
(scale bars: 40 and 6 μm, for (1) and (2−3), respectively). (B) (1) Simulated streamlines and (2) midplane contours of the normalized
velocity at different Re (white and black legend indicating normalized velocities of 1 and 0, respectively). Steady flow at Re = 30.3−122, and
a periodic oscillation of the central vortex at Re = 203−366 can be seen (scale bars representing 20 and 6 μm, for (1) and (2), respectively).
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To examine the interface between the fluid streams near the
crossover region in more detail, a confocal microscope
(FV1000, Olympus, Tokyo, Japan) was employed. It can be
seen in Figure 2A (2−3), that, with the further increase in Re,
an anticlockwise spiral vortex developed beyond Rec, and the
spiral expanded both vertically and horizontally. The vortex
pattern and Rec onset for the crossover agree very well with
previous studies, in which the spiral vortex was measured at the
mm scale.31,40,41
To gain deeper insights, we also performed numerical
analysis, using OpenFOAM42 (see Materials and Methods for
numerical computation details). Each experimental cross-
junction case (Figure 2A) was solved as an incompressible
fluid, and analyzed with respect to the presence of both steady-
state and transient flows. In addition, near Rec, the flow
increased with a step size of Re = 2, and transitioned into a
central vortex at Re = 36, which was in agreement with the
experiments. Minor discrepancies can be attributed to
geometrical differences in the polydimethylsiloxane (PDMS)
deformation (bulging) and to fabrication imperfections.
The fluid solver reaches a tightly converged (velocity and
pressure residuals below 10−7), steady-state solution, at Re =
30.3, 37.9, and 122 (Movie S4). At Re = 203, the steady-state
residual tolerance is not met; thus, a transient incompressible
solver was applied. Compared with the solution at Re = 122,
where the vortex core was static, the vortex at Re = 203
oscillates perpendicular to the inlets, primarily in the direction
of the Z-axis (Figure 2B (2) (iv), and Movie S5). At higher
flow rates and Re = 285 and 366, the oscillation of the core
vortex becomes more elliptical in the XZ plane, and pulse-like,
with the vortex periodically encountering the walls of the
channel and breaking apart before reforming (Movie S6), all of
which explains the cells’ intrinsic deformation behaviors at
different Re, as observed in our experiments.
Vortex Breakdown-Induced Cell Trapping and De-
formation. The spiral hydroporator is designed to open cell
membranes by rapidly deforming cells via spiral vortex and cell
wall collisions in a sequential manner (Figure 1). After passing
the first spiral cell deformation region, unexpected cell trapping
phenomena were observed (Movie S7). As was strikingly
shown in Figure 3A, slightly above the stagnation point, a cell
travels up and down repeatedly, for approximately 30 μs, and
then migrates toward the outlet. To quantify the strength of
this cell-trapping dependency on Re, we defined the
normalized time of trapping (T* = tU/L, where t is the time
necessary for the cell to escape the trapping region, U is the
average fluid velocity, and L is the trapping region length; see
Figure S1 for the geometric configuration). Normalized time is
introduced here to avoid the misconception that a faster flow
rate corresponds to a shorter cell trapping time (i.e., less cell
deformation), which is not the case in our study. As presented
in Figure 3B, the normalized time for trapping and cell
deformation increased with increasing Re, and this extra cell
perturbation is considered to enhance nanoparticle delivery
(details are provided in the section below).
Our observation agrees well with recent work by Vigolo et
al.,43 who reported bubble trapping at the T-junction, and
Chan et al.,44 who discussed low-density particle trapping at
the T-junction. Those trapping incidents were felt to have been
based on recirculating flow, also known as vortex breakdown,
which often develops when the vorticity decay is presented by
swirling flows.45 On the vortex axis, pressure gradients are
generated in the opposite direction of the outlet flows, toward
the center of the cross,30 allowing cells to travel against the
flow (Figure 3A), appearing to be trapped. In previous
studies,43,44 bubbles or low-density particles compared with the
carrier fluid (water) were used, but here we report that cells
and rigid spheres (Figure 3C), with density values similar or
slightly higher to that of the carrier fluid, can also be trapped.
Note that rigid polystyrene beads could not be trapped as
efficiently as cells (data not shown), possibly due to a shape-
Figure 3. Vortex breakdown-induced cell trapping and deformation. (A) High-speed microscopic images showing MDA-MB-231 cell
trapping behavior caused by vortex breakdown (Re = 285). (B) Normalized time of trapping as a function of Re. (Insets) Representative cell
deformation images for corresponding Re (error bars: mean ±1 SD, N = 3). (C) Image showing a rigid, 4.8 μm fluorescent bead becoming
trapped, at Re = 203, due to vortex breakdown. The yellow circles indicate the two trapping regions caused by channel symmetry (all scale
bars: 20 μm).
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dependent drag46 that was associated with the centrifugal
force.
Characterization of Intracellular Dextran Delivery.
The spiral hydroporation process allows target nanomaterials
to be transported through the created nanoholes on the cell
membrane, yielding highly efficient intracellular delivery. To
characterize spiral hydroporator delivery performance, we first
tested delivery of 3−5 kDa fluorescein isothiocyanate (FITC)-
conjugated dextran into MDA-MB-231 cells. We chose MDA-
MB-231 as our delivery vehicle because it is reportedly one of
the more difficult cell lines for dextran delivery.27 Details can
be found in the Materials and Methods section, but briefly, we
injected the mixture of cells and nanomaterials into the spiral
hydroporator, collected and washed them, and imaged the cells
after 18 h. As presented in Figure 4A, strong FITC signals were
detected for cells treated with the spiral hydroporator, and not
for the endocytosis control group.
To assess the delivery amount, we measured the
fluorescence signal intensity of each cell, using a flow
cytometer (see Materials and Methods section). As previously
reported,21 we defined the delivery efficiency as the fraction of
the fluorescence signals above 5% (red dotted line in Figure
4B) after delivery, which was set as the endocytosis control
(gray shading in Figure 4B), accounting for the endocytosis,
autofluorescence, and surface binding of the FITC-dextran. As
shown in Figure 4B,C, at Re = 366, approximately 96.5%
delivery efficiency was achieved, and as the Re increased, the
fluorescence intensity increased, causing the histogram profile
to shift to the right, which implies that we can control the
delivery amount by adjusting the Re deterministically. Note
that the level of delivery must be understood from the mean
fluorescence intensity (MFI) values as well and has been
plotted in Figure S2.
We also characterized the dependency of delivery efficiency
on the sample (cell) concentration and observed that delivery
efficiency started to decrease if the sample concentration
became higher than 4 × 106 cells/mL (Figure S3). Thus, at Re
= 366, with a sample concentration of approximately 2 × 106
cells/mL, a total throughput of 1 × 106 cells/min was achieved.
It must be emphasized that the entire delivery process takes
approximately 1 min, representing rapid intracellular nanoma-
terial delivery.
With respect to cell viability (determined by the trypan blue
exclusion method; see Materials and Methods section for
Figure 4. Characterization of intracellular dextran delivery. (A) Bright-field and fluorescent images showing delivery of 3−5 kDa FITC-
dextran into MDA-MB-231 cells via (1) endocytosis (control) and (2) spiral hydroporation, after 18 h (scale bar: 40 μm). (B) Fluorescence
intensity histograms at different Re. (C) Delivery efficiency and (D) cell viability as a function of Re. (E) Dependence of delivery efficiency
on different dextran sizes. (F) Delivery efficiency for 2000 kDa FITC-dextran in the cases of a cross-junction and a combination of cross- and
T-junctions. (G) Comparisons of delivery efficiency by either electroporation or spiral hydroporation, for 500 and 2000 kDa FITC-dextran.
All error bars except (E) indicate the mean ±1 SD (N = 3), and *** represents a P-value below 0.001. The error bars in (E) represent
maximum and minimum boundaries, with the straight lines in the box showing the median, and the diamond markers indicating the mean
(N = 6).
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details), at higher flow rates (i.e., higher Re), a minor decrease
in viability could be observed (Figure 4D). This is to be
expected, as cell perturbation is significantly greater at higher
Re; however, the difference in cell morphology and
proliferation between spiral hydroporation and endocytosis
was found to be negligible (Figure S4). To investigate cell
viability further, via metabolic function, a standard MTT
assay47 was carried out (Materials and Methods section).
Overall trends between trypan blue exclusion and MTT assays
agreed well with each other, while MTT assays showed slightly
lower viability values at high Re numbers (Figure 4D).
Recently Liu et al.48 reported that when cells were processed
with mechanical deformation for intracellular delivery, they still
maintained high nuclear envelope integrity and underwent low
protein loss (i.e., high cell membrane integrity). Since this work
is also based on rapid cell deformation-enabled nanomaterial
delivery, we consider that cells processed with our spiral
hydroporator also preserve their nuclear and membrane
integrity.
Next, we tested the effect of nanomaterial size on the
delivery. Dextrans having molecular weights in the range 3−
2000 kDa, corresponding to a hydrodynamic diameter between
2−55 nm,49,50 were used. Under the same flow conditions (Re
= 366), we calculated delivery efficiencies for five different
FITC-dextran sizes (3−5, 70, 150, 500 and 2000 kDa) at the
same concentration (see Materials and Methods for details).
As shown in Figure 4E, delivery efficiency of at least 80% was
achieved using our platform (see Figure S5 for MFI
information). Relatively small dextrans (<70 kDa) were seen
to have a higher delivery efficiency compared to larger ones
(Figure 4E). For small dextrans, it is believed that both
convective and diffusive transport of dextran across the cell
membrane occurs, while convective transport dominates the
transport of larger dextrans as suggested by Liu et al.24 and
Kizer et al.27 We noticed that delivery efficiency remained at a
similar level (∼82%), even as the dextran size increased from
150 to 2000 kDa. This trend suggested that there was potential
for larger molecules to be delivered, and in testing this concept,
we were subsequently able to deliver 200 nm diameter GNPs
(more details in the next section).
As discussed in the Design and Operating Principle section,
the platform consists of a cross-junction and two T-junction
channels (Figure 1), in which cells undergo sequential
deformation−restoration processes. We hypothesized that
this repeated deformation−restoration enhances delivery
efficiency, and so to test this, a mixture of cells and 2000
kDa FITC-dextran was injected into (1) a channel with a
cross-junction and (2) a channel with cross- and T-junctions,
at Re = 366. The resultant delivery efficiencies have been
plotted in Figure 4F (the results for other dextran sizes are
plotted in Figure S5 and MFI information is presented in
Figure S6). The figure shows that the sequential hydrodynamic
cell perturbations exhibit a higher FITC-dextran delivery,
which agreed well with results published for constriction-based
intracellular delivery platforms, passing cells through bottle-
necks in series.21,24
To compare our platform with the most popular intracellular
delivery method, that is, electroporation, a Neon Transfection
System (Thermo Fisher Scientific, Waltham, MA, USA) was
employed. Note that we also prepared a plot (Figure S7) for
detailed comparison between this work and other state-of-the-
art microfluidic devices21,24−27,51 tested under identical or
similar concentrations. We delivered large (500 and 2000 kDa
FITC-dextran) molecules into the same cell line, using two
methods. For 2000 kDa FITC-dextran delivery, the spiral
hydroporator exhibited approximately 4-fold higher delivery
efficiency (Figure 4G; MFI values in Figure S8A) and showed
∼13% higher viability than the electroporator (Figure S8B).
With regards to analyte consumption, based on the recipe
recommended by the electroporator manufacturer, spiral
hydroporation consumed approximately 2.5 times more than
standard electroporation, per cell, when the same FITC-
dextran concentration was used. This may be a potential
drawback for spiral hydroporation, although adopting a
Figure 5. Intracellular delivery of GNPs (200 nm diameter). Dark-field scattering images verifying GNP delivery by (A) spiral hydroporation
(SH), (B) electroporation (EP), and (C) endocytosis (EC) (scale bar: 20 μm). (Inset) TEM image of a GNP (scale bar: 100 nm). (D)
Scattering spot counts, (E) cell viability, and (F) normalized yield for each method. All error bars represent the mean ±1 SD (N = 3); ***
indicates a P-value below 0.001, **** indicates a P-value blow 0.0001, and ***** indicates a P-value below 0.00001.
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pressure-driven flow control system36 could be a simple
solution, allowing significant sample volume (i.e., mass)
reduction.
Intracellular Delivery of Gold Nanoparticles. As briefly
discussed, based on recent developments in the field of
nanotechnology, a wide array of functional GNPs has been
created, for numerous biological applications;52 however,
delivery to their biological targets at the subcellular level,
with high efficiency and specificity, remains challenging. We
hypothesized that our spiral hydroporator could be applied for
GNP delivery, on the assumption that the vigorous spiral
hydroporation process would facilitate delivery of large
nanoparticles, such as GNPs, into cells.
To test this hypothesis, a series of GNP delivery experiments
was performed. As shown in Figure 5A, extremely large GNPs
(200 nm in diameter) were successfully delivered into MDA-
MB-231 cells, via spiral hydroporation. To characterize this
delivery, GNPs were imaged using dark-field microscopy (BX
43, Olympus, Tokyo, Japan); the scattering spots were counted
and are shown in Figures 5D and S9. Note that not every
scattering spot translates into a single GNP. It has been
reported that nanoparticles tend to form clusters under
cytosolic conditions, due to exposure to ions and protein,53,54
so the scattering spots here indicate clustered GNPs in the cell,
after delivery. An electroporator was also applied, to create a
reference used in a performance comparison with hydro-
poration, and almost 10 times more scattering spots were
observed for cells treated with the spiral hydroporation
platform compared to those treated using the electroporator.
The electroporator was able to deliver GNPs as well, although
only a small number of scattering spots were detected (Figure
5B); this was to be expected, as it has been established that
electroporation is not effective in transporting large nanoma-
terials (here GNPs), due to large counteracting effects of
Stokes drag.
To confirm the GNP locations inside cells, a confocal
microscope was employed for the imaging.55 As presented in
Figure S10 and Movie S8, most GNPs were seen in the cytosol,
while some GNPs appeared in the nucleus region. This
indicates that hydroporation may open the nucleus envelope,
facilitating nucleus delivery, although further investigation into
this concept is required.
We also investigated cell viability, and the results showed
that the electroporator is more invasive to cells (Figure 5E).
Regarding cell morphology (Figure 5A−C), cells treated with
the spiral hydroporator were closer to the control endocytosis
group, while those processed with the electroporator were
rounder, implying that these cells underwent more stress.56 We
also calculated the normalized yield, by multiplying the
scattering spot number by cell viability (Figure 5F), in a
yield that can be used to directly compare overall performance.
The results indicated that the spiral hydroporation platform is
more than three times as effective, with respect to the GNP
delivery.
Intracellular Delivery of Functional Nanoparticles.
We also investigated the possibility of using the spiral
hydroporator to deliver functional nanoparticles. In this
study, we chose 150 nm (diameter) mesoporous silica
nanoparticles (MSNs), as popularly used for drug, protein,
and nucleic acid nanocarriers. MSNs loaded with doxorubicin
(DOX), an anticancer drug (the preparation steps in Materials
and Methods section), were delivered to MDA-MB-231 cells
using the spiral hydroporator, although other chemical choices
can be made for various applications, depending on user
needs.57 At DOX-MSN delivery completion, the delivery
amount was assessed, based on the intrinsic DOX fluorescence.
As shown in Figure 6A−C, compared with endocytosis
controls, cells treated with the spiral hydroporator showed
much more intense fluorescence.
We also monitored morphological changes to the cells,
testing the assumption that higher DOX delivery amounts led
to faster cell death. After 2 h, cells treated with the spiral
hydroporation platform were not polarized (i.e., they showed a
rounded shape), and morphological apoptosis features (Figure
6C at 6 h point) were observed. These morphological changes
can be attributed to the fact that the DOX induces apoptosis,58
leading to rapid cell death, and this was particularly clear for
cells that had been processed with spiral hydroporation. DOX
cytotoxicity to MDA-MB-231 cells was also determined using a
trypan blue exclusion assay, as shown in Figure 6D, and after 6
h, approximately 85% of the cancer cells were found to be
dead. Based on these results, we believe that our platform will
be useful for investigating DOX-induced apoptosis, avoiding
traditional surface ligands-based DOX delivery.
Figure 6. Intracellular delivery of MSNs. Bright-field and fluorescent images showing the cells during the delivery of doxorubicin-loaded
MSNs for the (A) negative control, (B) positive control (cells coincubated with DOX-MSNs), and (C) spiral hydroporation (scale bar: 40
μm). (D) Time-dependent cell viability changes for (A−C). All error bars represent the mean ±1 SD (N = 3).
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Intracellular Delivery of mRNA. Beyond nanoparticle
delivery applications, we tested delivery of synthetic bio-
molecules, in this study, mRNAs. The mRNA (a basic,
constitutively fluorescent, green fluorescent protein, EGFP,
which is a 996-nucleotide mRNA construct) was chosen here
for delivery into K562 cells to investigate the possibility of
using the spiral hydroporation platform for chimeric antigen,
receptor-expressing T-cell (CAR-T), engineering-associated
research. We assessed the EGFP protein expression, based
on mRNA delivery (2 μg/mL), using a flow cytometer, and the
results are presented in Figure 7A,B (see Figure S11 for MFI
information). After mRNA delivery, very strong EGFP signals
were detected (Figure 7D), and a delivery efficiency of ∼92%
was achieved, without sacrificing cell viability (Figure 7E,F),
indicating our platform’s high potential for use in immuno-
therapy research, although further investigation is required to
test human immune cells.
CONCLUSIONS
This work shows the use of intrinsic spiral cell deformation
behavior originating from an instability-induced spiral vortex
and vortex breakdown, in cross- and T-junction channels at
moderate Re, for the intracellular delivery of nanomaterials. We
have developed and validated a spiral hydroporation platform
(a spiral hydroporator), which delivers various nanomaterials,
including dextran, mRNA, GNP, and DOX-MSN. In contrast
to other conventional delivery approaches, our method is
characterized by a high efficiency, material/species-independ-
ency (including suspension cell lines) and robustness, while
achieving a low-cost, rapid, and simple operation. The platform
does not require vectors, special buffers, or external
instrumentation such as imaging microscopes, cameras, or
voltage sources. Syringe pumps are the only technology
required and are used to inject the cells mixed with the target
nanomaterials into a PDMS microfluidic chip, demonstrating
the high practicability and portability of the system. We
compared our system with an existing, state-of-the-art tool, an
electroporator, and other representative microfluidic platforms
and were able to demonstrate superior performance. In
conclusion, we envision that the spiral hydroporator will
serve as an attractive intracellular nanomaterial delivery
platform, influencing cell biology-associated research.
MATERIALS AND METHODS
Fabrication of Microfluidic Intracellular Device. The micro-
fluidic mold was fabricated using conventional photolithography, and
polydimethylsiloxane (PDMS, Dow Corning Corporation, Corning,
NY, USA) replicas were prepared using standard PDMS-molding
protocols.
Flow Simulation. Flow through the cross-junction channel was
simulated by the fluid dynamics software OpenFOAM.42 The channel
was numerically approximated using inlets and outlets at 19Dh from
the midpoint of the junction and 4 μm chamfers at the corners of the
constriction. A hexahedral mesh was generated by first constructing a
uniform grid in the blockMesh utility and then using the
snappyHexMesh function to incorporate the constricted section
edge features. A no-slip boundary condition was applied to all walls. A
uniform velocity was set for the inlets, and the pressure at the outlets
was set to zero. Steady-state solutions were calculated using
simpleFOAM, and transience was investigated using the icoFOAM
solver. Both solvers have a residual tolerance of 10−7 for velocity and
pressure. A mesh convergence study was conducted at Re = 100, by
iteratively refining the background grid and checking the relative error
of the steady-state midpoint vorticity. Compared with a 37.1 × 106
cell case, the relative error dropped to 2%, based on the use of 8.4 ×
106 cells, and to 1%, based on the use of 16.0 × 106 cells (chosen as a
suitable mesh).
Flow Visualization. 10 μM Rhodamine 6G (Sigma-Aldrich, MO,
USA) was added to DI water for flow visualization, and fluorescence
was captured using a Zeiss Axio Observer A1 inverted microscope
(Carl Zeiss, Oberkochen, Germany), equipped with an Andor Luca-R
EMCCD camera (Oxford Instruments, Abingdon, UK).
Cell Preparation. MDA-MB-231 and K562 cells were cultured
using standard protocols and resuspended in cell media with the
target nanomaterial. For mRNA (Trilink Biotechnologies; CA, USA)
delivery, Opti-MEM (Thermo Fisher Scientific, MA, USA) was used
as a delivery buffer, for stabilization. 40 μm cell strainers (Thermo
Fisher Scientific, MA, USA) were used to filter dust from the cell
suspensions before loading them into syringes. MDA-MB-231 and
K562 cell lines were purchased from the Korean Cell Line Bank
(Seoul, Republic of Korea).
Cell Viability. Cell viability was characterized by trypan blue
exclusion assay (Lonza, MD, USA) and/or MTT assay (Thermo
Fisher Scientific, MA, USA). Protocols recommended by the
manufacturers were used for both assays. Triplicate sampling or
more was conducted for each data point.
FITC-Dextran Delivery. All FITC-dextran materials (3−2000
kDa) were purchased from Sigma-Aldrich (MO, USA), and regardless
of dextran sizes, every experiment was conducted using a
concentration of 0.3 mg/mL delivery buffer (cell media). The mass
of fluorophores in solution was identical across all molecules sizes.24
For the endocytosis control group, cells were incubated with identical
FITC-dextran during the spiral hydroporation process, and extra
FITC-dextrans were washed via centrifugation.
Intracellular Delivery and Cell Motion Analysis Protocols.
Cell suspensions were injected using syringe pumps (Harvard
Apparatus, MA, USA), with injection conducted only from the left-
Figure 7. Intracellular delivery of mRNA. Fluorescence intensity
histograms for: (A) endocytosis and (B) spiral hydroporation.
Bright-field and fluorescent images showing delivery of the mRNA
into K562 for EGFP expression via (C) endocytosis and (D) spiral
hydroporation (scale bar: 40 μm). (E) Delivery efficiency and (F)
cell viability results for cells treated with endocytosis and spiral
hydroporation. All error bars represent the mean ±1 SD (N = 3).
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hand side, to prevent two cells from simultaneously entering the
deformation zone and affecting each other. Cell motions were
recorded using a Phantom VEO710L high-speed camera (Vision
Research, NJ, USA), with a frame rate between 250,000 and 680,000
frames/s and an exposure time ranging from 600 ns to 1 μs. Images
were processed using ImageJ (https://imagej.nih.gov/ij/). Normally,
a concentration of 5 × 105 cells/mL was used, and all fluorescence
images were acquired 18 h after delivery, except for DOX-MSN
images.
Flow Cytometry. Cell fluorescence was assessed using a flow
cytometer (Guava easyCyte, EMD Millipore, MA, USA), a 488 nm
laser for excitation, and a 533/30 nm emission filter for FITC and
EGFP. Data analysis was carried out using Guava easyCyte software
(guavaSoft 3.3).
Electroporation Protocols. Cells were processed with a Neon
Transfection System (Thermo Fisher Scientific, MA, USA), using the
specified buffer (Resuspension Buffer R) recommended by the
manufacturer, depending on the cell type.
Gold Nanoparticle Synthesis and Size Characterization.
Citrate-capped GNPs were synthesized in the laboratory using
standard synthesis protocols,59,60 and their sizes were characterized
using an energy-filtering transmission electron microscope (LIBRA
120, Carl Zeiss, Oberkochen, Germany) and particle size analyzer
(ELS-Z2, Otsuka Electronics, Osaka, Japan). All samples were
analyzed in triplicate, and a GNP concentration of optical density
(OD) of 0.02 was used.
DOX-MSN Delivery. Prior to delivery, DOX-MSN was prepared
following procedures published in the literature.54,61 Briefly, MSNs
were fabricated with the sol−gel method, and the MSN suspension
was mixed with DOX solution (500 μg/mL), with an equivalent
volume. In the last step, the MSN surface was modified with
aminosilane, in aqueous solution, to prevent undesired leakages. After
purification, the DOX-MSN was redispersed into the PBS as a stock.
Cells with the diluted DOX-MSN (5 μg/mL) were tested at Re = 346,
and cell fluorescence was recorded for up to 6 h, using a Zeiss Axio
Observer A1 inverted microscope (Carl Zeiss, Oberkochen,
Germany).
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